U.S. markets open in 4 hours 54 minutes
  • S&P Futures

    4,216.25
    +6.25 (+0.15%)
     
  • Dow Futures

    33,321.00
    +61.00 (+0.18%)
     
  • Nasdaq Futures

    13,415.00
    +23.00 (+0.17%)
     
  • Russell 2000 Futures

    1,973.80
    +4.30 (+0.22%)
     
  • Crude Oil

    92.05
    +0.12 (+0.13%)
     
  • Gold

    1,802.60
    -11.10 (-0.61%)
     
  • Silver

    20.42
    -0.32 (-1.53%)
     
  • EUR/USD

    1.0331
    +0.0029 (+0.28%)
     
  • 10-Yr Bond

    2.7860
    0.0000 (0.00%)
     
  • Vix

    20.04
    -1.73 (-7.95%)
     
  • GBP/USD

    1.2227
    +0.0009 (+0.07%)
     
  • USD/JPY

    132.5780
    -0.2950 (-0.22%)
     
  • BTC-USD

    24,463.29
    +1,430.60 (+6.21%)
     
  • CMC Crypto 200

    575.78
    +44.56 (+8.39%)
     
  • FTSE 100

    7,504.74
    -2.37 (-0.03%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Quantum-Si to Report Second Quarter 2022 Financial Results on August 8, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

GUILFORD, Conn., July 18, 2022--(BUSINESS WIRE)--Jul. 18, 2022--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing the first next generation single molecule protein sequencing, today announced that it will report financial results for the second quarter 2022 after market close on Monday, August 8, 2022. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 p.m. ET.

Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.

About Quantum-Si Incorporated

Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220718005731/en/

Contacts

Investor
Juan Avendano
ir@quantum-si.com

Media
Karen Chase
QSI-PR@westwicke.com